300702 天宇股份
已收盘 08-26 15:00:00
资讯
新帖
简况
天宇股份(300702.SZ)拟出资7000万元参与设立德方鸿景股权投资基金
智通财经 · 08-05
天宇股份(300702.SZ)拟出资7000万元参与设立德方鸿景股权投资基金
天宇股份：拟认缴7000万元参与设立投资基金 出资比例49.96%
格隆汇 · 08-05
天宇股份：拟认缴7000万元参与设立投资基金 出资比例49.96%
股市必读：天宇股份新发布《关于全资子公司产品拟中选第十二批全国药品集中采购的公告》
证券之星 · 08-05
股市必读：天宇股份新发布《关于全资子公司产品拟中选第十二批全国药品集中采购的公告》
天宇股份（300702）披露回购公司股份进展公告，8月4日股价上涨7.09%
证券之星 · 08-04
天宇股份（300702）披露回购公司股份进展公告，8月4日股价上涨7.09%
天宇股份(300702.SZ)：盐酸曲唑酮片等拟中选第十二批全国药品集中采购
智通财经 · 08-04
天宇股份(300702.SZ)：盐酸曲唑酮片等拟中选第十二批全国药品集中采购
天宇股份（300702）披露提前归还闲置募集资金公告，7月28日股价上涨0.65%
证券之星 · 07-28
天宇股份（300702）披露提前归还闲置募集资金公告，7月28日股价上涨0.65%
7月17日天宇股份跌7.33%，湘财医药健康混合A基金重仓该股
证券之星 · 07-17
7月17日天宇股份跌7.33%，湘财医药健康混合A基金重仓该股
天宇股份（300702）披露控股股东部分股份补充质押及质押展期公告，7月6日股价下跌0.64%
证券之星 · 07-06
天宇股份（300702）披露控股股东部分股份补充质押及质押展期公告，7月6日股价下跌0.64%
天宇股份（300702）披露回购公司股份比例达到1%暨回购股份进展的公告，7月2日股价上涨0.71%
证券之星 · 07-02
天宇股份（300702）披露回购公司股份比例达到1%暨回购股份进展的公告，7月2日股价上涨0.71%
天宇股份(300702.SZ)：美阿沙坦钾片获得药品注册证书
智通财经 · 07-01
天宇股份(300702.SZ)：美阿沙坦钾片获得药品注册证书
7月1日天宇股份涨5.41%，湘财医药健康混合A基金重仓该股
证券之星 · 07-01
7月1日天宇股份涨5.41%，湘财医药健康混合A基金重仓该股
天宇股份（300702）披露收购上海星可高纯溶剂有限公司部分股权暨关联交易进展公告，6月26日股价下跌4.21%
证券之星 · 06-26
天宇股份（300702）披露收购上海星可高纯溶剂有限公司部分股权暨关联交易进展公告，6月26日股价下跌4.21%
6月23日天宇股份涨5.08%，湘财医药健康混合A基金重仓该股
证券之星 · 06-23
6月23日天宇股份涨5.08%，湘财医药健康混合A基金重仓该股
天宇股份（300702）披露全资子公司药品获得批准的公告，6月22日股价上涨1.69%
证券之星 · 06-22
天宇股份（300702）披露全资子公司药品获得批准的公告，6月22日股价上涨1.69%
天宇股份(300702.SZ)子公司阿帕他胺片获得药品注册证书
智通财经 · 06-22
天宇股份(300702.SZ)子公司阿帕他胺片获得药品注册证书
每周股票复盘：天宇股份（300702）首次回购股份52,100股
证券之星 · 06-21
每周股票复盘：天宇股份（300702）首次回购股份52,100股
天宇股份（300702）披露首次回购公司股份公告，6月17日股价上涨1.15%
证券之星 · 06-17
天宇股份（300702）披露首次回购公司股份公告，6月17日股价上涨1.15%
天宇股份拟回购8000万元至1.3亿元公司股份
北京商报 · 06-11
天宇股份拟回购8000万元至1.3亿元公司股份
天宇股份（300702）股东屠勇军质押50万股，占总股本0.14%
证券之星 · 06-10
天宇股份（300702）股东屠勇军质押50万股，占总股本0.14%
天宇股份最新公告：拟8000万元至1.3亿元回购股份
证券之星 · 06-10
天宇股份最新公告：拟8000万元至1.3亿元回购股份
加载更多
公司概况
公司名称：
浙江天宇药业股份有限公司
所属行业：
医药制造业
上市日期：
2017-09-19
主营业务：
浙江天宇药业股份有限公司的主营业务是中间体、原料药以及制剂业务的研发、生产与销售。公司的主要产品是缬沙坦、厄贝沙坦、氯沙坦钾、坎地沙坦酯、奥美沙坦酯、沙坦联苯系列、孟鲁司特钠、盐酸西格列汀、磷酸西格列汀、维格列汀、依折麦布、替格瑞洛。
发行价格：
22.41
{"stockData":{"symbol":"300702","market":"SZ","secType":"STK","nameCN":"天宇股份","latestPrice":21.65,"timestamp":1787727804000,"preClose":21.57,"halted":0,"volume":1322659,"delay":0,"changeRate":0.0037,"floatShares":210000000,"shares":348000000,"eps":0.2751,"marketStatus":"已收盘","change":0.08,"latestTime":"08-26 15:00:00","open":21.52,"high":21.81,"low":21.32,"amount":28599000,"amplitude":0.0227,"askPrice":21.69,"askSize":10,"bidPrice":21.65,"bidSize":25,"shortable":0,"etf":0,"ttmEps":0.2751,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787794200000},"marketStatusCode":5,"adr":0,"adjPreClose":21.57,"symbolType":"stock","openAndCloseTimeList":[[1787707800000,1787715000000],[1787720400000,1787727600000]],"highLimit":23.73,"lowLimit":19.41,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":347977159,"isCdr":false,"pbRate":2.04,"roa":"--","peRate":78.698655,"roe":"1.15%","epsLYR":0.41,"committee":0.322082,"marketValue":7534000000,"turnoverRate":0.0063,"status":0,"floatMarketCap":4555000000},"requestUrl":"/m/hq/s/300702","defaultTab":"news","newsList":[{"id":"2657446005","title":"天宇股份(300702.SZ)拟出资7000万元参与设立德方鸿景股权投资基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2657446005","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657446005?lang=zh_cn&edition=full","pubTime":"2026-08-05 20:12","pubTimestamp":1785931923,"startTime":"0","endTime":"0","summary":"智通财经APP讯，天宇股份 发布公告，公司与上海德鸿私募基金管理中心、临海市靖越金融投资集团有限公司、临海市瀚海投资有限公司在浙江省台州市临海市签署了《合伙协议》，共同投资设立浙江德方鸿景股权投资合伙企业。该基金总认缴出资额为1.40亿元，其中公司作为有限合伙人以自有资金认缴出资7000万元，出资比例为49.96%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1476458.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300702","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657546919","title":"天宇股份：拟认缴7000万元参与设立投资基金 出资比例49.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657546919","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657546919?lang=zh_cn&edition=full","pubTime":"2026-08-05 19:11","pubTimestamp":1785928264,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["300702","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657656965","title":"股市必读：天宇股份新发布《关于全资子公司产品拟中选第十二批全国药品集中采购的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657656965","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657656965?lang=zh_cn&edition=full","pubTime":"2026-08-05 02:43","pubTimestamp":1785868990,"startTime":"0","endTime":"0","summary":"全资子公司诺得药业盐酸曲唑酮片、甲苯磺酸艾多沙班片拟中选第十二批全国药品集中采购。公司公告汇总关于全资子公司产品拟中选第十二批全国药品集中采购的公告浙江天宇药业股份有限公司全资子公司浙江诺得药业有限公司参与第十二批全国药品集中采购，产品盐酸曲唑酮片和甲苯磺酸艾多沙班片拟中选；采购周期自中选结果执行之日起至2029年12月31日；相关采购协议签订及后续事项存在不确定性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500002287.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300702","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656522505","title":"天宇股份（300702）披露回购公司股份进展公告，8月4日股价上涨7.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656522505","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656522505?lang=zh_cn&edition=full","pubTime":"2026-08-04 22:38","pubTimestamp":1785854297,"startTime":"0","endTime":"0","summary":"截至2026年8月4日收盘，天宇股份报收于21.61元，较前一交易日上涨7.09%，最新总市值为75.2亿元。该股当日开盘20.33元，最高21.75元，最低20.33元，成交额达1.34亿元，换手率为2.98%。公司于2026年8月4日披露《关于回购公司股份进展的公告》。公告显示，浙江天宇药业股份有限公司于2026年6月10日召开第六届董事会第二次会议，审议通过《关于回购公司股份方案的议案》，拟使用自有资金以集中竞价交易方式回购公司股份，用于员工持股计划或股权激励计划。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400041681.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300702","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656364145","title":"天宇股份(300702.SZ)：盐酸曲唑酮片等拟中选第十二批全国药品集中采购","url":"https://stock-news.laohu8.com/highlight/detail?id=2656364145","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656364145?lang=zh_cn&edition=full","pubTime":"2026-08-04 16:43","pubTimestamp":1785833019,"startTime":"0","endTime":"0","summary":"智通财经APP讯，天宇股份(300702.SZ)发布公告，公司全资子公司浙江诺得药业有限公司参加了国家组织药品联合采购办公室(简称“联采办”)组织的第十二批全国药品集中采购的投标工作，根据联采办于2026年7月31日在上海阳光医药采购网发布的《第12批国家组织药品集中带量采购拟中选结果公示》显示，公司产品盐酸曲唑酮片和甲苯磺酸艾多沙班片拟中选本次集中采购。拟中选产品的采购周期自中选结果执行之日起至2029年12月31日。若后续采购合同顺利签订并实施，预计将进一步提升该产品销量和市场占有率，增强公司品牌影响力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475763.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","300702"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654008522","title":"天宇股份（300702）披露提前归还闲置募集资金公告，7月28日股价上涨0.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654008522","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654008522?lang=zh_cn&edition=full","pubTime":"2026-07-28 17:46","pubTimestamp":1785231973,"startTime":"0","endTime":"0","summary":"截至2026年7月28日收盘，天宇股份报收于20.08元，较前一交易日上涨0.65%，最新总市值为69.87亿元。该股当日开盘19.87元，最高20.39元，最低19.82元，成交额达4002.34万元，换手率为0.95%。近日，天宇股份发布《关于提前归还暂时补充流动资金的闲置募集资金的公告》。公司实际使用7,000.00万元，已于2026年7月2日提前归还4,000.00万元，剩余3,000.00万元于2026年7月28日全部归还至募集资金专用账户，使用期限未超过12个月，并已通知保荐机构及保荐代表人。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072800028946.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300702","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652060994","title":"7月17日天宇股份跌7.33%，湘财医药健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2652060994","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652060994?lang=zh_cn&edition=full","pubTime":"2026-07-17 16:55","pubTimestamp":1784278525,"startTime":"0","endTime":"0","summary":"证券之星消息，7月17日天宇股份跌7.33%，收盘报20.23元，换手率2.5%，成交量5.27万手，成交额1.1亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为湘财基金的湘财医药健康混合A。湘财医药健康混合A目前规模为0.4亿元，最新净值1.7379，较上一交易日上涨0.77%，近一年上涨13.78%。湘财医药健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700030700.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300702","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649316628","title":"天宇股份（300702）披露控股股东部分股份补充质押及质押展期公告，7月6日股价下跌0.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649316628","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649316628?lang=zh_cn&edition=full","pubTime":"2026-07-06 17:47","pubTimestamp":1783331221,"startTime":"0","endTime":"0","summary":"截至2026年7月6日收盘，天宇股份报收于21.8元，较前一交易日下跌0.64%，最新总市值为75.86亿元。公告显示，公司控股股东林洁女士持有公司股份122,028,474股，占公司总股本的35.07%。林洁女士办理了部分股份补充质押及质押展期业务：其中，补充质押300万股，占其所持股份比例2.46%；质押展期1,050万股，原质押起始日为2025年7月7日，展期后到期日为2027年7月6日。本次变动后，林洁女士累计质押股份2,500万股，占其持股总数的20.49%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070600025492.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300702"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648686923","title":"天宇股份（300702）披露回购公司股份比例达到1%暨回购股份进展的公告，7月2日股价上涨0.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648686923","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648686923?lang=zh_cn&edition=full","pubTime":"2026-07-02 22:49","pubTimestamp":1783003754,"startTime":"0","endTime":"0","summary":"截至2026年7月2日收盘，天宇股份报收于21.4元，较前一交易日上涨0.71%，最新总市值为74.47亿元。近日，天宇股份发布《关于回购公司股份比例达到1%暨回购股份进展的公告》。截至2026年6月30日，已回购股份2,959,500股，占总股本的0.85%，成交金额60,590,428元。截至2026年7月2日，累计回购股份3,823,850股，占总股本的1.10%，成交金额78,931,481.50元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200042482.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300702"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648516405","title":"天宇股份(300702.SZ)：美阿沙坦钾片获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2648516405","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648516405?lang=zh_cn&edition=full","pubTime":"2026-07-01 16:57","pubTimestamp":1782896265,"startTime":"0","endTime":"0","summary":"智通财经APP讯，天宇股份(300702.SZ)发布公告，公司全资子公司浙江诺得药业有限公司(以下简称“诺得药业”)于近日收到国家药品监督管理局(以下简称 “国家药监局”)核准签发的关于美阿沙坦钾片的《药品注册证书》。公司产品美阿沙坦钾片获得国家药监局批件后可在境内生产、销售，进一步丰富了公司的制剂品种规格，有望增加公司制剂业务收入，有助于提升公司产品的市场竞争力，对公司的经营业绩产生积极的影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1461870.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"天宇股份(300702.SZ)：美阿沙坦钾片获得药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300702","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648516445","title":"7月1日天宇股份涨5.41%，湘财医药健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2648516445","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648516445?lang=zh_cn&edition=full","pubTime":"2026-07-01 16:53","pubTimestamp":1782896023,"startTime":"0","endTime":"0","summary":"证券之星消息，7月1日天宇股份涨5.41%，收盘报21.25元，换手率2.64%，成交量5.55万手，成交额1.15亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为湘财基金的湘财医药健康混合A。湘财医药健康混合A目前规模为0.4亿元，最新净值1.5575，较上一交易日下跌2.19%，近一年上涨7.51%。湘财医药健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100031728.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300702","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646365488","title":"天宇股份（300702）披露收购上海星可高纯溶剂有限公司部分股权暨关联交易进展公告，6月26日股价下跌4.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646365488","media":"证券之星","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646365488?lang=zh_cn&edition=full","pubTime":"2026-06-26 22:39","pubTimestamp":1782484754,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，天宇股份报收于20.24元，较前一交易日下跌4.21%，最新总市值为70.43亿元。天宇股份于近日披露《关于收购上海星可高纯溶剂有限公司部分股权暨关联交易的进展公告》。公告显示，公司于2026年3月30日召开董事会，审议通过收购屠勇军等八名交易对方合计持有的上海星可高纯溶剂有限公司87.8173%股权，交易价格为33,370.57万元。公司已督促南京梧聚解除冻结，推进剩余股权交割。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600045850.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300702"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645881467","title":"6月23日天宇股份涨5.08%，湘财医药健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2645881467","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645881467?lang=zh_cn&edition=full","pubTime":"2026-06-23 16:40","pubTimestamp":1782204032,"startTime":"0","endTime":"0","summary":"证券之星消息，6月23日天宇股份涨5.08%，收盘报21.51元，换手率3.96%，成交量8.32万手，成交额1.79亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为湘财基金的湘财医药健康混合A。湘财医药健康混合A目前规模为0.4亿元，最新净值1.5675，较上一交易日上涨0.38%，近一年上涨10.92%。湘财医药健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300028154.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300702","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645807582","title":"天宇股份（300702）披露全资子公司药品获得批准的公告，6月22日股价上涨1.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645807582","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645807582?lang=zh_cn&edition=full","pubTime":"2026-06-22 22:51","pubTimestamp":1782139877,"startTime":"0","endTime":"0","summary":"截至2026年6月22日收盘，天宇股份报收于20.47元，较前一交易日上涨1.69%，最新总市值为71.23亿元。该股当日开盘19.88元，最高20.57元，最低19.16元，成交额达9461.69万元，换手率为2.27%。近日，浙江天宇药业股份有限公司全资子公司浙江诺得药业有限公司收到国家药品监督管理局核准签发的阿帕他胺片《药品注册证书》，药品批准文号为国药准字H20264862，有效期至2031年6月16日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200039307.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300702"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645804023","title":"天宇股份(300702.SZ)子公司阿帕他胺片获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2645804023","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645804023?lang=zh_cn&edition=full","pubTime":"2026-06-22 16:48","pubTimestamp":1782118086,"startTime":"0","endTime":"0","summary":"智通财经APP讯，天宇股份(300702.SZ)发布公告，公司全资子公司浙江诺得药业有限公司于近日收到国家药品监督管理局核准签发的关于阿帕他胺片的《药品注册证书》。该药品适应症为：转移性内分泌治疗敏感性前列腺癌(mHSPC)成年患者;有高危转移风险的非转移性去势抵抗性前列腺癌(NM-CRPC)成年患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1456897.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"天宇股份(300702.SZ)子公司阿帕他胺片获得药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","300702"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645309604","title":"每周股票复盘：天宇股份（300702）首次回购股份52,100股","url":"https://stock-news.laohu8.com/highlight/detail?id=2645309604","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645309604?lang=zh_cn&edition=full","pubTime":"2026-06-21 03:43","pubTimestamp":1781984590,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，天宇股份报收于20.13元，较上周的19.47元上涨3.39%。本周，天宇股份6月18日盘中最高价报20.38元。天宇股份当前最新总市值70.05亿元，在化学制药板块市值排名68/150，在两市A股市值排名2572/5206。上述担保在公司2025年年度股东会授权范围内，无需另行审议。截至目前，国内另有10家企业该原料药通过CDE技术审评。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062100001279.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300702","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644120217","title":"天宇股份（300702）披露首次回购公司股份公告，6月17日股价上涨1.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644120217","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644120217?lang=zh_cn&edition=full","pubTime":"2026-06-17 17:35","pubTimestamp":1781688949,"startTime":"0","endTime":"0","summary":"截至2026年6月17日收盘，天宇股份报收于19.39元，较前一交易日上涨1.15%，最新总市值为67.47亿元。该股当日开盘19.2元，最高19.85元，最低18.84元，成交额达6924.82万元，换手率为1.7%。公司于2026年6月17日披露《关于首次回购公司股份的公告》。本次回购符合公司回购方案及相关法律法规的要求。公司后续将在回购期限内根据市场情况择机实施股份回购，并及时履行信息披露义务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061700030605.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300702","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642287021","title":"天宇股份拟回购8000万元至1.3亿元公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2642287021","media":"北京商报","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2642287021?lang=zh_cn&edition=full","pubTime":"2026-06-11 21:12","pubTimestamp":1781183520,"startTime":"0","endTime":"0","summary":"6月11日晚间，天宇股份（300702）披露公告称，公司拟使用自有资金以集中竞价交易的方式回购公司部分社会公众股份，用于实施员工持股计划或股权激励计划。 公告显示，公司本次回购价格不超过30.18元/股，回购资金总额不低于8000万元且不超过1.3亿元，预计回购股份数量约为265.08万股至430.75万股，占公司总股本的0.76%至1.24%。（文章来源：北京商报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-06-11/doc-iniazyek2250044.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-06-11/doc-iniazyek2250044.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","300702"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642428816","title":"天宇股份（300702）股东屠勇军质押50万股，占总股本0.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2642428816","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2642428816?lang=zh_cn&edition=full","pubTime":"2026-06-10 18:43","pubTimestamp":1781088227,"startTime":"0","endTime":"0","summary":"证券之星消息，天宇股份6月10日公开信息显示，股东屠勇军向云南国际信托有限公司合计质押50.0万股，占总股本0.14%。质押详情见下表：截止本公告日，股东林洁已累计质押股份2200.0万股，占其持股总数的18.03%，股东屠勇军已累计质押股份1580.0万股，占其持股总数的27.67%。天宇股份主营业务：中间体、原料药以及制剂业务的研发、生产与销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061000035365.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300702"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642447663","title":"天宇股份最新公告：拟8000万元至1.3亿元回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2642447663","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2642447663?lang=zh_cn&edition=full","pubTime":"2026-06-10 18:01","pubTimestamp":1781085701,"startTime":"0","endTime":"0","summary":"天宇股份(300702.SZ)公告称，公司拟使用自有资金以集中竞价方式回购股份，资金总额不低于8000万元且不超过1.3亿元，回购价格不超过30.18元/股。回购股份将用于实施员工持股计划或股权激励计划，实施期限为自董事会审议通过之日起6个月内。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061000032011.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300702","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1787773396035,"stockEarnings":[{"period":"1week","weight":-0.0326},{"period":"1month","weight":0.0852},{"period":"3month","weight":0.1335},{"period":"6month","weight":-0.1321},{"period":"1year","weight":-0.2186},{"period":"ytd","weight":-0.0802}],"compareEarnings":[{"period":"1week","weight":0.0046},{"period":"1month","weight":0.0141},{"period":"3month","weight":-0.0454},{"period":"6month","weight":-0.0601},{"period":"1year","weight":0.0114},{"period":"ytd","weight":-0.0142}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江天宇药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"14955人(较上一季度增加4.09%)","perCapita":"14069股","listingDate":"2017-09-19","address":"浙江省台州市黄岩区黄岩江口化工开发区","registeredCapital":"34797万元","survey":" 浙江天宇药业股份有限公司的主营业务是中间体、原料药以及制剂业务的研发、生产与销售。公司的主要产品是缬沙坦、厄贝沙坦、氯沙坦钾、坎地沙坦酯、奥美沙坦酯、沙坦联苯系列、孟鲁司特钠、盐酸西格列汀、磷酸西格列汀、维格列汀、依折麦布、替格瑞洛。","listedPrice":22.41},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"天宇股份(300702)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供天宇股份(300702)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"天宇股份,300702,天宇股份股票,天宇股份股票老虎,天宇股份股票老虎国际,天宇股份行情,天宇股份股票行情,天宇股份股价,天宇股份股市,天宇股份股票价格,天宇股份股票交易,天宇股份股票购买,天宇股份股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"天宇股份(300702)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供天宇股份(300702)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}